Medtech grants in Canada

Scheduled

Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.

Scheduled

Funds three €5–7M projects that make cancer control more equitable, effective and cost-aware for patients and families.

Scheduled

Funds two €12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.

Scheduled

Funds €8–10M procurer consortia to bring affordable cancer technologies, devices and medicines from tender to patient benefit.

Scheduled

Funds one €3M coordination action that helps cancer charities and funders improve quality of life for young survivors across Europe.

Scheduled

Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.

Scheduled

Funds €10–12M projects that make Virtual Human Twins useful for prevention, diagnosis and safer clinical decisions.

Scheduled

Funds a European community and roadmap for trustworthy frontier AI models in healthcare.

Between cycles

Invests in scale-up ventures in digital, clean technology, and biotechnology through equity to accelerate commercialization pathways.

Between cycles

Funds innovative SME-led international R&D consortia through the Eurostars Call 12 grant process.

Between cycles

Runs students and early career scholars with mentoring support for CRF Postdoctoral Research Fellowship in biotechnology, medical technology, and synthetic biology.

Between cycles

Administers research teams and institutions for CRF Research Grant in biotechnology, medical technology, and synthetic biology.

Between cycles

Supports EIC beneficiaries' participation in major trade fairs across the EU, MENA and the US.

Between cycles

Funds early-stage deep tech startups developing solutions at TRL 4-5 in collaboration with industry partners through a 4-month co-creation programme.

Between cycles

Supports international consortia so small companies can turn joint innovation into export-ready products.

Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.

Closed

Funds early clinical trials of therapies built from the molecules cells secrete rather than the cells themselves, aiming for an off-the-shelf alternative to cell therapy.

Closed

Pays cash prizes to teams that build and validate generative AI solutions for enhancing clinical datasets or generating automatic test cases from crash databases.

Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.

Closed

Funds wearable devices and apps, paired with behavioural coaching, that help 12-to-25-year-olds build habits that prevent the most common non-cancer chronic diseases later in life.

Closed

Funds small, SME-majority consortia running an early-phase clinical trial to move a biotech therapy, from antibodies to RNA therapies, from the lab towards the market.

Funds public-private research on the determinants of health, from prevention and early diagnosis to new vaccine strategies and disease-outbreak preparedness.

Funds public-private research on new health technology assessment methods that value combined, integrated healthcare innovations fairly.

Funds public-private research that makes integrated healthcare solutions feasible and better matched to what patients and citizens actually need.